| 000 | 02928nam a22004935i 4500 | ||
|---|---|---|---|
| 001 | 978-1-60761-262-9 | ||
| 003 | DE-He213 | ||
| 005 | 20140220083734.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100907s2011 xxu| s |||| 0|eng d | ||
| 020 |
_a9781607612629 _9978-1-60761-262-9 |
||
| 024 | 7 |
_a10.1007/978-1-60761-262-9 _2doi |
|
| 050 | 4 | _aRB1-214 | |
| 072 | 7 |
_aMMF _2bicssc |
|
| 072 | 7 |
_aMED067000 _2bisacsh |
|
| 082 | 0 | 4 |
_a616.07 _223 |
| 100 | 1 |
_aCrisan, Domnita. _eeditor. |
|
| 245 | 1 | 0 |
_aHematopathology _h[electronic resource] : _bGenomic Mechanisms of Neoplastic Diseases / _cedited by Domnita Crisan. |
| 264 | 1 |
_aTotowa, NJ : _bHumana Press : _bImprint: Humana Press, _c2011. |
|
| 300 |
_aXII, 360 p. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 | _aMolecular and Translational Medicine | |
| 505 | 0 | _aChapter 1: Molecular techniques used in Hematopathology -- Chapter 2: Cytogenetics techniques used in Hematopathology -- Chapter 3: The molecular component of the new WHO classification of hematologic malignancies -- Chapter 4: Molecular pathology of pediatric acute leukemias -- Chapter 5: Molecular pathology of adult acute leukemias -- Chapter 6: Molecular pathology of lymphomas -- Chapter 7: Molecular pathology of chronic myeloproliferative neoplasms -- Chapter 8: Molecular pathology of CLL -- Chapter 9: Targeted therapy in hematologic malignancies -- Chapter 10: MicroRNAs in hematologic malignancies. | |
| 520 | _aHematopathology: Genomic Mechanisms of Neoplastic Diseases will keep physicians abreast of the rapid and complex changes in genomic medicine, as exemplified by the molecular pathology of hematologic malignancies. This timely volume will update physicians on the complexities of genomic lesions, as well as offer an integrated framework encompassing molecular diagnosis, the new WHO classification of hematologic neoplasms with focus on molecular pathology, prognostic value of molecular tests, and molecular monitoring of response to gene-targeted therapy. As such, it will be of great value to hematologists, oncologists, pathologists, internal medicine and pediatric specialists, as well as bioscientific staff and laboratorians in private hospitals and academic institutions. | ||
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aHematology. | |
| 650 | 0 | _aOncology. | |
| 650 | 0 | _aPathology. | |
| 650 | 1 | 4 | _aMedicine & Public Health. |
| 650 | 2 | 4 | _aPathology. |
| 650 | 2 | 4 | _aHematology. |
| 650 | 2 | 4 | _aMolecular Medicine. |
| 650 | 2 | 4 | _aOncology. |
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9781607612612 |
| 830 | 0 | _aMolecular and Translational Medicine | |
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-1-60761-262-9 |
| 912 | _aZDB-2-SME | ||
| 999 |
_c106356 _d106356 |
||